FS9-54761-93773
2 vaccinations
6 coded responses
24 check-ins
6 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 559 / MN
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — day 14, dose 2MedDRA: Rash, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continue to have a rash/hives.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-17
Survey response — day 21, dose 2MedDRA: Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I was evaluated for post-vaccination hives that are still persistent but manageable.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Self-medication, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Continue to have hives widespread. They are becoming less responsive to antihistamine use.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-03
Survey response — day 35, dose 2MedDRA: Angioedema, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Diffuse hives all over body. 2 incidences of angioedema of the lips. Currently in prednisone as a result. Hives being evaluated by Dermatology and Allergy in 2 upcoming appointments. I additionally continue to take high dose OTC antihistamines.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-10
Survey response — day 42, dose 2MedDRA: Eye swelling, Laryngitis, Lip swelling, Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Full body hives, and lip and eye swelling, laryngitis. Currently on steroids.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-28
Survey response — 3 months, dose 2MedDRA: Angioedema, Urticaria chronic — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Have experienced 3 episodes of angioedema since my 2nd vaccination end of January. Now under the care of an allergist from chronic urticaria.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-14
-
2021-06-14
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-28
- 2022-01-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech |
Call center
6 call center cases
6 successful
Free text
Release 4 — day 14, dose 2
Symptoms: Continue to have a rash/hives.
Release 4 — day 21, dose 2
Symptoms: I was evaluated for post-vaccination hives that are still persistent but manageable.
Release 4 — day 28, dose 2
Symptoms: Continue to have hives widespread. They are becoming less responsive to antihistamine use.
Release 5 — day 35, dose 2
Symptoms: Diffuse hives all over body. 2 incidences of angioedema of the lips. Currently in prednisone as a result. Hives being evaluated by Dermatology and Allergy in 2 upcoming appointments. I additionally continue to take high dose OTC antihistamines.
Release 5 — day 42, dose 2
Symptoms: Full body hives, and lip and eye swelling, laryngitis. Currently on steroids.
Release 8 — 3 months, dose 2
Symptoms: Have experienced 3 episodes of angioedema since my 2nd vaccination end of January. Now under the care of an allergist from chronic urticaria.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Angioedema | ✓ | ✓ | ✓ |
| SD | Antiallergic therapy | ○ | ○ | ○ |
| SD | Eye swelling | ✓ | ✓ | ✓ |
| SD | Laryngitis | ✓ | ✓ | ✓ |
| SD | Lip swelling | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SD | Urticaria chronic | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release